This grant funds clinical research or trials on non-drug interventions to improve dementia care for Alzheimer's patients and caregivers, requiring preliminary data and community collaboration.
Funder: Dept. of the Army -- USAMRAA
Due Dates: June 22, 2026: Pre-Application (Preproposal) | September 24, 2026: Full Application | September 29, 2026: End of Application Verification Period
Funding Amounts: ~$5.4M total; up to $1.6M (single PI) or $1.9M (CIT Partnership Option) per award for up to 4 years; ~3 awards expected.
Summary: Supports clinical research or trials evaluating interventions, innovations, and solutions in dementia care for individuals with Alzheimer’s disease or related dementias and their care partners.
Key Information: Community collaboration required for studies prospectively enrolling human subjects; clinical trials of pharmacological interventions and animal studies are not allowed.
This opportunity, administered by the Dept. of the Army -- USAMRAA through the Congressionally Directed Medical Research Programs (CDMRP), funds clinical research or clinical trials that evaluate interventions, innovations, and solutions addressing critical needs in dementia care for individuals with Alzheimer’s disease and Alzheimer’s disease related dementias (AD/ADRD) and their care partners. Projects must be non-incremental, solution-oriented, and designed to have a significant impact on care quality, caregiver burden, and quality of life. Research may address knowledge gaps, interventions, strategies, technologies, or tools, and should consider both those living with dementia and their care partners. Community collaboration is required for research prospectively enrolling human subjects.
Distinctive features: